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New insight into the catalytic mechanism of chorismate 
mutases from structural studies 
Chorismate mutase catalyzes the rearrangement of chorismic acid to prephenic acid, 
which is the first committed step in the biosynthesis of aromatic amino acids. Its 
catalytic mechanism has been much studied, but is poorly understood. Recent 
structural information on enzymes from two species, and on an antibody 
that catalyzes the same reaction, has shed new light on this topic. 
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Chorismic acid is the key branch point intermediate in [I 7-211. As well as these approaches, the mzyme has been 
the +kimate pathway of bacteria. fLungi, and higher studied by NMK and infrared spectroscopy [Y-Z], and 
plants [I ]. It can be converted either into prephenic acid, theoretical calculations have been used to propose models 
evmtually leading to tyrosine and phenylalanine, or into for the transition state involved in rexrangement 
mtliranildte. eventually producing tryptophan. The [3,29-331. Genetic, immunological, and evolutionary 
intramolecular rearrangement of chorismic acid to analyws [33-3.53 have also provided information on the 
prephenic acid (Fig. 1) is catalyzed by chorismate mutate. characteristics of the eiizyiiie. 
Thi\ enzyme accelerates the reaction some two million- 
fold, yet. despite its central role in the aromatic biosyw Efforts to mimic the catalytic mechanism of chorimlate 
thetic pathway. the enzyme’s catalytic mechanism mutase have ranged from the design of cimple cryptandc 
relnains poorly underctood [3,3]. Recent structural (crypt-like, bridged cro\vn ethers) [36] to the production 
studies on sweral naturally occuring chorismate mutases of monoclonal antibodies generated against a putative 
[4-h], and on m mtibody that catalyzes the same reac- transition-state analog 137,38].Two groups have ,lchieved 
tion 171, mav now have provided some insight into the antibod~-ill~di~lt~[~ catalysis of the rearrangement of 
catalytic nlcchanisnx used by these proteins. (-)-chorismic acid: antibody 1 F7 [7.30,40] gave a rate 
enhancemrnt of 2JO-fold, while antibody 1 1 Fl -2E1 1 
Interdisciplinary studies on chorismate mutax by 
chenusts, biochemists and enzymologists have taken many 
forn~s.The kinetics of the reaction have been investigated 
using wlvcnt, substituent, and isotope effects [3.8-131; 
protein modific,xtion has been used to identie key 
amino-acid residues [ 14-l 61, and several competitive 
inhibitors and alternative substrates have been synthesized 
[-I I ] gave a 1 O’-fold rate enhancement. 
Structural studies on chorismate mutases 
Recently, detailed structural infornlatioll has been 
obtained on several naturally occurring chorismate 
mutates, and on mtibody 1 F7. X-ray crystal structures of 
the enzyme from Ba~i//ns rrfbtilir [J-C,] and of antibody 
Fig. 1. The rearrangement of chorismic 
acid (7) to prephenic acid (2). The pre- 
sumed transition state is shown, 
together with the transition state analog 
inhibitor (3) used in X-ray crystallo- 
graphic. studies. This [3,3[-pericyclic 
process is formally analogous to a 
Claisen rearrangement. 
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Fig. 2. The active site of E. co/i chorismate m&se. (a) A space-filling model of the active site of the chorismate mutase domain of the E. 
co/i P-protein complexed with transition-state analog inhibitor 3 as defined by a 2.2 p\ resolution X-ray diffraction analysis [42]. (b) 
Schematic diagram of the hydrogen bonding and electrostatic interactions of the transition-state inhibitor 3 with the relevant side 
chains of EcCG. 
IF7 171 were obtained in complex with the inhibitor 
Fhown as compound 3 in Fig. 1. Most recently, we have 0 
been able to determine the 2.2 A resolution X-ray struc- 
ture of the monofunctional amino-terminal chorismate 
mutase domain (E&M) engineered from the bifunc- 
tional E.&ric/~io m/i enzyme chorismate niutase- 
prephenate dehydratase (P- protein) 1431 in complex with 
inhibitor 3. Comparison of the three structurec allows an 
informed evaluation of the various mechanistic hypothe- 
ses which have been advanced for chorismate nlutase 
catalysis. Both the B. mbrilis and the E. c-o/i mutases 
appear to exploit electrostatic and hydrogen bonding 
effects in an unusual fashion to achieve catalysis. 
The f. co/i chorismate mutase 
EcCM consists of residues l-l 09 of the P-protein. It has 
three helical segments (residues h-42, 39-65, 70-l 00) 
mhich cause the peptide backbone to adopt a shape like 
the figure 1. Coiled-coil and helix-helix interactions 
between the two longest segments create a catalytically 
functional, elongated honmdimrr with two equivalent, 
elbo\v-shaped active sites that are highly charged and 
completely enclosed. Although access to the active site is 
possible from different directions, as might be expected 
in the parent bifuuctional enzyme, charged Arg, Asp and 
Glu side-chain residues on different faces of the protein 
shield the catalytic region from solvent (Fig. 2). 
The B. subfilis enzyme 
The R. r~tbtilis chorismate ulutase (BsCM) is also mono- 
functional, and of comparable size to EcCM. Although 
the kinetic parameters of EcCM and BsCM are similar, 
both the amino-acid sequence and the secondary struc- 
ture of BsCM are strikingly different. Standard alignment 
methods indicate less than 20 “/;I similarity in the EcCM 
and BsCM sequences (indeed, there is very little 
sequence similarity between any of the known mutases 
from different organisms). The high-resolution crystal 
structure of BsCM in complex with compound 3 [4,5] 
shows that the peptide backbone ofBsCM adopts a five- 
stranded mixed P-sheet containing one a-helix (residues 
1X-34) and a two-turn 3,,, helix. BsCM is a symmetric 
trinler packed to form a pseudo-&P-barrel, with adj,- 
cent subunits forming three equivalent clefts that consti- 
tute the active sites. In striking contrast to EcCM, the 
active site in BsCM is open and accessible to solvent, and 
the protein itself makes no important contacts with the 
Cl 0 carboxyl group of the inhibitor (Fig. 3). 
The catalytic antibody 1 F7 
The three-dimensional structure of the monoclonal cat- 1 
alytic antibody 1 F7 has been determined to 3.0 A reso- 
lution as the Fab’-inhibitor complex 1401. Ligand 
binding occurs at the confluence of six loops made up 
of heavy (Hl-H3) and light (Ll-L3) chain variable 
domains. The active site displays a bowl-like shape or 
cleft, and interacts with compound 3 using a combina- 
tion of electrostatic, hydrogen bonding, and hydropho- 
bic effects (Fig. 4). As with most antibodies to small 
molecules, ligand cornplernentarity resides mainly on 
the heavy chain; only a single residue of the light chain 
(Tyr-L94) interacts with compound 3.The active site of 
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(b) 
Fig. 3. The active site of B. subtilis chorismate mutase. (a) Space;filling model of the active site of 6. subtilis chorismate mutase com- 
plexed with transition-state analog inhibitor 3 as defined by a 1.9 A resolution X-ray diffraction analysis [4]. (b) Schematic diagram of the 
hydrogen bonding and electrostatic interactions of transition-state analog inhibitor 3 with the relevant side chains of E&CM. 
IF7 thus resembles those of E&M and BsCM in that 
the active sites of these enzymes are also dimeric, and 
the contacts again consist mainly of contributions from 
one monomer chain. 
The rearrangement of chorismate to prephenate is a 
one substrate-one product process, and is one of very 
few chemical transformations where the enzymatic 
process can be compared directly with its unimolecular 
solution counterpart.The uncatalyzed rearrangement of 
chorismate to prephenate occurs about 10” times faster 
than the rearrangement of ally1 vinyl ether [20,43], and 
for this reason has attracted considerable interest. It 
seems reasonable that an understanding of the intrinsi- 
cally fast rearrangement of chorismate might shed light 
on, or provide clues about, the nature and role of sub- 
stl-ate and transition-state binding interactions in the 
mutase process. 
Both the enzymatic and non-enzymatic reactions 
proceed via chair-conformation transition structures 
[ 10.1 1 1. Secondary tritium isotope effects on the uncat- 
alyzed rearrangement are evident at C.5 (C-O bond- 
breakage), but not at CY (C-C bond formation) [9]. No 
comparable i\otopc effect is seen in the mutase-cat- 
atyzed rearrangement, although a small (k,/k, = 0.96) 
inverse secondary isotope effect is observed by tritiation 
at CJ- [ 121. Judging from activation parameters for a 
variety of catalysts (Table I), and assuming that activa- 
tion parameters for EcCM and BsCM resemble the 
other nati\:e enzymes sl~own in Table 1, the ability of 
mutases to restrict conformational degrees of freedom is 
important in promoting rearrangement. In the case of 
1 F7, however, the activation parameters suggest that the 
antibody’s modest rate acceleration results from a reduc- 
tion in AH* for the reaction 1391 rather than from 
entropic control. 
Substrate conformation 
How does chorismate mutase achieve the experimentally 
observed enhancement in the rate of chorismate 
rearrangement? Several possible ways have been sug- 
gested. Since the entropy of activation is reduced effec- 
tively to zero in the catalyzed process (Table l), the 
enzyme-substrate complex must orient the ring of the 
substrate in the pseudo-diaxial conformation, while rota- 
tion about C5-07 and U-07 must be severely 
restricted to lock the enol pyruvate side chain in the 
rearranging chair conformer. As lo-20 % of chorismate 
exists as the pseudo-diaxial form in dynamic equilibrium 
Table 1. Activation enthalpy and entropy for the rearrangement 
of compound 1 to compound 2. 
Catalyst hHS (kcal mol-‘) AS* (e.u.) References 
S. aureofaciens 14.5 -2.2 2 
A. aerogenes 15.9 -1.1 2 
IF7 15 -22 37 
llFl-2Ell 18.3 -1.2 38 
Uncatalyzed 20.5 -12.9 7,16 
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Fig. 4. The active site of antibody 1 F7. (a) Space-filling model of the hinding site of antibody 1 F7, which has chorismate mutase acitivity, 
complexed with transition-state analog inhibitor 3 as defined by a 3.0 8\ resolution X-ray diffraction analysis 1401. (b) Schematic diagram of 
the hydrogen bonding and electrostatic interactions of transition-state analog inhibitor 3 with the relevant side chains of antibody 1 F7. L, 
light chain residue: H. heavv chain residue. Antibodv 1 F7 was venerated by linking hapten 3 at the C4-hydroxyl group to a carrier protein, 
<I 
thus biasing the modi of ligind binding. 
with the pseudo-diequatorial form, Knowles and col- 
leagues [25] have suggested that the enzyme binds the 
diaxial conformer, and that the enzyme-substrate 
complex then undergoes rearrangement via some inter- 
mediate from which product formation is rapid. The 
inverse secondary tritium kinetic isotope effect at C4 
noted earlier is thus rationalized in terms of the effect of 
tritium on the conformational equilibrium of chorismate 
(T prefers to be equatorial; thus, k,,/kT = 0.95). 
Enzyme-substrate binding 
The functional groups of chorismate offer several possi- 
bilities for noncovalent binding in the enzyme-substrate 
complex (see Fig. 1). For example, the two charged car- 
boxylate groups are capable of strong electrostatic inter- 
actions with protonated active-site residues. Suitable 
partners may also form H-bonds with chorismatei car- 
boxy1 and hydroxyl groups. Inhibition studies with both 
aliphatic and aromatic diacids indicate that the vinyl 
ether oxygen is important [21,24], and that hydrophobic 
forces may contribute to binding [2]. Finally, there is the 
possibility of r-electron interactions with chorismate’s 
diene system [ 21. 
There have been a number of attempts to observe the 
enzynie-substrate complex and other ligand interactions 
directly using 13C-NMK [26,27]. Although neither free 
nor bound chorismate can be detected, difference spectra 
reveal significant perturbations between C5 and C6 in 
bound prephenate, perhaps caused by changes in electron 
density and/or molecular geometry in that region 
127,281. In support of the role of electrostatic inter- 
actions, studies using synthetic analogs and esters of cho- 
rismate indicate that the only functional groups required 
on the ally1 vinyl ether framework in chorismate for 
mutase-catalyzed rearrangement are the two carboxylic 
acid groups 1231. 
The X-ray crystal structures of EcCM and BsCM 
provide useful information on enzyme-substrate complex 
formation. When the two active sites are compared by 
superimposing the atoms of the bound inhibitor, con- 
pound 3, a common motif emerges in the highly charged 
region created by the presence of adjacent, protonated 
residues (Lys30, Argl 1’ and Arg5 I in EcCM; Arg90 and 
Arg7 in &CM). This electropositive wall interacts 
strongly with the left flank (Cl-C4) of chorismate 
through an elaborate network of bridging H-bonds 
involving both 07 and the Cl 1 carboxylate of the en01 
pyruvate (Figs 2b, 3b). In retrospect, an early clue to this 
concentration of positive charge came from the work of 
Gorisch, who concluded from inhibition of the 
Stvc~pronl)~ccs auvr~ficieur~ mutase by small inorganic anions 
that at least two cationic groups were present in the 
active site 121. Working with E. roli chorismate mutase- 
prephenate dehydratase (the source of EcCM), Gething 
and Davidson [ 151 further noted the singular importance 
of a lysine residue (almost certainly Lys3’3; Fig. 2b) whose 
modification led to complete loss of mutase activity 
without affecting the dehydratase domain. 
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Conformational trapping 
Besides promoting enzyme-substrate complex formation 
through electrostatic effects, the positively charged 
residues in the EcCM active site are strategically 
arranged to orient and lock chorismate in the requisite 
chair conformer for rearrangement.We propose that free 
chorismate may enter the active site in extended confor- 
mation, shown as structure 4 in Figure 5, which mini- 
mizes electrostatic and n-n repulsive interactions. Initial 
contact between the enol pyruvate carboxylate and 
Lys39 forms an electrostatic bond. Clockwise rotation 
about CS-07 enables the side-chain carboxylate group 
to form a second H-bond to Argl l’, as shown in struc- 
ture 5. Further clockwise rotation forms the highly stabi- 
lized guanidine-carboqlate pairing shown in structure 6, 
together with a third H-bond between 04 and Lys39, 
ef&ctively freezing the rotation of the carboxylate group 
about U-Cl 1 and suspending the enol ether n-system 
over the carbocyclic ring, approximately parallel to an 
axis defined by C2-C4. An incremental rotation about 
C.5-07 forms a fourth H-bond between 03 and the 
tightly bound water molecule bridging Argll’ and 
ArgS 1. With its structure gradually made more compact 
through favorable H-bonding and electrostatic effects, 
chorismate ic thus drawn deeper into the active site as 
the rearranging conformation is achieved in the 
enzynie-substrate complex. At the same time, an electron 
lone pair on 07 becomes accessible for H-bonding to 
Lyc39 and GlnXri of EcCM (. see structure 7; this will be 
discussed further below). 
Comparable entropic restriction of chorismate by &CM 
could also result from similar interactions between the 
Cl 1 carbosylate of chorismate (see Fig. 1) and Arg90, 
Arg7 and Tyr108, which bring 07 into proximity with 
Asp48 and Glu52. Antibody 1 F7, however, contains only 
a single cationic residue (Arg-HS)S).The X-ray structure 
of 1 F7 Lvith bound compound 3 indicates just two H- 
bonds to the C 11 carboxylate, and no side-chain residues 
are within H-bonding distance of 07. Instead of acting 
like an entropy trap, this protein displays an unfavorable 
decrease in ASP (Table 1). 
What is the role of the Cl0 carboxylate ion in substrate 
binding? It has been shown that the E. mli enzyme will 
not catalyze the rearrangement of dimethyl chorismate, 
C I O-monomethyl or Cl I -monomethyl chorismate 1231. 
This absolute requirement of EcCM for both of the car- 
boxylic acid groups of chorismate is perhaps not surpris- 
ing in view of the additional H-bonding interactions 
between Arg2X and SerX4 and the Cl0 carboxylate of 
conlpound 3 (Fig. 2b). In contrast, HsCM forms no 
active site contacts with the ring carboxyl group of the 
substrate, and it is not known whether this enzyme can 
promote the rearrangement of Cl 1 -monomethyl choris- 
mate. Given the quite similar steady-state kinetic profiles 
of &CM (k,,, = 50 s-l; K, = 100 FM) [43] and EcCM 
(Ic~,,~ = 72 SC’, K, = 290 PM) [4S] and their comparable 
behavior 1%.ith inhibitor 3 (K1 = 3 FM for &CM; K, = 
2 PM for EcCM) (H.B. Wood, Jr & B.G., unpublished 
OH 
4 
Fig. 5. Conformational trapping of chorismate during the forma- 
tion of the complex with EcCM. Chorismate may initially bind in 
an extended conformation (structure 4), forming an initial hydro- 
gen bond between 03 and Lys39. Rotation around the C5-07 
bond then allows formation of a second hydrogen bond; 04 
replaces 03 in the hydrogen bond to Lys39, while 03 moves to 
hydrogen-bond to Argl 1’ (structure 5). Further rotation around 
the C5-07 bond moves 03 to yet another position (structure 6) 
and increases the number of hydrogen bonds formed to three. 
Rotation is highlighted by the shaded rectangle, whose long axis 
lies along the 07~C8 bond. Once the rotation is complete, a 
lone pair of electrons becomes accessible for hydrogen bonding 
to Lys39 and Gln88 (structure 7). At this point, the substrate is 
essentially frozen in a conformation close to that of the transition 
state. E-S complex, enzyme-substrate complex. 
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data) it seems probable that the two enzymes have similar 
mechanisms; this would imply that the Cl0 carboxylate 
has a relatively minor role in substrate binding for 
both enzymes. 
Complexes of EcCM or BsCM with substrate may also 
derive additional noncovalent stabilization from the for- 
mation of two H-bonds with the C4 allylic alcohol (05). 
In EcCM, 05 has one H-bond each with Asp48 and with 
the y-carboxyl of Glu52 (Fig. 2). Comparable H-bonds 
are seen with Glu78 and Cys75’ in BsCM (Fig. 3). The 
importance of these interactions in enzyme-substrate 
complexation is not clear. In the case of the E. di bifunc- 
tional enzyme chorismate mutase-prephenate dehydroge- 
nase (the T-protein: a second mutase similar to the 
P-protein), the C4 hydroxyl of chorismate is apparently 
not essential for substrate binding, since both 4-deoxycho- 
rismate and chorismate methyl ether are substrates for 
mutase-catalyzed rearrangement 1231. Comparable tests 
with these substrates using BsCM have not been reported. 
However, indirect evidence from studies on the E. c&T- 
protein suggest that Cys75’ in BsCM is important in 
binding chorismate. Of the four cysteines identified in the 
T-protein, alkylation of one with iodoacetamide results in 
complete loss of mutase activity [16]. Since only one cys- 
teine (Cys96) is found in the amino-terminal (i.e. mutase) 
domain of the T-protein, that residue may have a role 
comparable to that of Cys75’ in BsCM. Similar modifica- 
tion studies on the E. coli P-protein (from which EcCM 
originates) indicate that none of the four cysteines in the 
structure is directly involved in mutase activity 1161. 
The catalytic mechanism 
Historically, most mechanistic hypotheses about choris- 
mate mutase have considered both carboxylic acid 
groups in the substrate to be important. Gorisch [2] pro- 
posed that chorismate binds the enzyme through ionic 
interactions at both carboxylates, with the requisite 
diaxial conformation gaining further stabilization 
from H-bonding. Alternatively, the enzyme-substrate 
complex, with salt bridges to both carboxylate anions 
restricting rotational freedom, may undergo a macro- 
molecular conformational change. According to this 
hypothesis, a torque is exerted on chorismate’s ally1 vinyl 
ether system, forcing Cl and C9 closer together to facili- 
tate rearrangement. Despite their elegance and simplicity, 
both of these hypotheses are invalidated by the fact that 
the Cl 0 carboxylate in BsCM, insofar as can be deter- 
mined from the X-ray structural data (Fig. 3), makes no 
significant bonding contacts with the enzyme [4,5]. 
Knowles and colleagues considered a mechanism in 
which anchimeric assistance by chorismate’s C4 hydroxyl 
might result in transient formation of an oxirinium ion 
1121. This mechanism cannot, however, explain the 
catalyzed rearrangement of 4-deoxychorismate and cho- 
rismate methyl ether mentioned earlier 1231. A rate- 
enhancing solvolysis of the C4-hydroxyl group, based on 
known substituent effects in pericyclic processes 143,461, 
is also excluded by the viability of +deoxychorismate 
as a mutase substrate (k,,, 21 s-‘; k,., for chorismate 
= 51 s-1) [12,23]. 
A nucleophile-assisted, dissociative pathway for choris- 
mate mutase-prephenate dehydrogenase mediated 
rearrangement has also been considered 1121. This 
hypothesis relies on the fact, first noted almost forty 
years ago by Goering and Jacobson 1471 and indepen- 
dently by White et al. [4X], that some Claisen rearrange- 
ments are more rapid in polar solvents.These processes 
are currently thought to involve dipolar or dissociated 
transition states [20,49], although Gajewski and col- 
leagues [50,51] have argued that the magnitude of the 
observed solvent effect is substantially weaker than 
would be expected if bond heterolysis were important. 
As depicted in structure 8 (Fig. 6), the enzyme-substrate 
complex could undergo rate-limiting, heterolytic cleav- 
age of the ether bond with general acid catalysis. 
Concomitant attack by an enzyme nucleophile leads to 
the covalently bound intermediate 9 which then forms 
l------+ 
1 ‘X-Em 
I :X-Enr 
Fig. 6. Hypothetical nucleophile- 
assisted pathway for chorismate mutase- 
prephenate dehydrogenase involving a 
dissociative transition state (see [121). 
The enzyme-substrate complex could 
be cleaved by a nucleophilic attack 
from the enzyme (see structure 
8) leading to a covalently bound 
intermediate (structure 9). The product 
could then be formed by expelling the 
nucleophile in an S,2’ process. 
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Fig. 7. An orbital diagram of n-T* conjugation in vinyl ethers, 
showing how hydrogen bonding disrupts the favorable resonance 
interaction. 
product by expelling the nucleophile in an S,3’ process. 
The observation of a significant D,O solvent isotope 
effect for the T protein (>2 on both kcnr and kcd,/K,) is 
consistent with a general acid-proton transfer in the 
rate-limiting step. 
III the case of BsCM, however, no 11,O solvent isotope 
effect is observed, and the enzymatic reaction is insensi- 
tive to acid or base [2h]. Although mechanistic deduc- 
tions based on solvent isotope effects are risky, the fact 
that no significant change in kc,,/K, is evident between 
pH 5-C) with BsCM argues against the participation of an 
ionizable nucleophilic group, including Cys75’. Gray and 
Knowles [2X] conclude from kinetic and spectroscopic 
parameters that the mutase reaction is an encounter-con- 
trolled pericyclic process, although perhaps asynchronous 
like its uncatalyzed counterpart. The enzymatic 
rearrangement is thought to be accelerated by selective 
binding of the reactive pseudodiaxial chair conformer, 
with some rate enhancement possible as a result of 
electrostatic stabilization of the transition state [as]. 
Hydrogen bonding 
X-rav crystallographic studies on EcCM and BsCM 
inhiditor complexes reveal another common structural 
motif which may be responsible for the lower AN of 
the catalyzed reaction. Each enzyme forms two H-bonds 
with 07 of the bound inhibitor (Figs 2b, 3b). In a recent 
Monte Carlo simulation of the effect of hydration on 
Claisen rearrangements, Severance and Jorgensen 1521 
show that the transition state for ally1 vinyl ether 
rearrangement in water is better hydrated than the reac- 
tant.The authors suggest that enhanced hydration, that is, 
increased H-bonding in water, may account for a several 
hundredfold rate enhancement over the Claisen 
rearrangement of ally1 vinyl ether in the gas phase. By 
disrupting the well known II-T* conjugation in vinyl 
ether\ IS-?], H-bonding would raise the energy of the 
reactant and reduce the activation enthalpy for 
rearrangement (Fig. 7). 
Thus, two effects might explain the observed accelera- 
tion of Claisen rearrangements in polar solvents: (i) stabi- 
lization of a heterolytic transition state through 
solvent-promoted dissociation, and/or (ii) destabilization 
of the reactant through hydrogen bonding with water or 
alcohols. Besides accommodating the concerns of 
Gajewski and colleagues over the magnitude of the 
observed solvent effects [50,51], this hydrogen-bonding 
effect suggests how chorismate mutases might reduce 
AH~. In the case of EcCM, formation of the 
enzyme-substrate complex 7 (Fig. 5) rotates the lone 
pairs on 07 of chorismate into position for H-bonding 
with Lys39 and Gln88. By disrupting n-r* conjugation 
in the conformationally constrained vinyl ether, H- 
bonding by these residues would raise the free enerW of 
the enzyme-substrate complex and reduce the activation 
enthalpy for rearrangement. 
The specific hydrogen bonds formed would depend on 
the detailed structure of the enzyme-substrate complex. 
If bound chorismate is conformationally constrained 
without H-bonding at 07, then two new H-bonds with 
Lys39 and GlnXX created in the transition state will sig- 
nificantly accelerate the rearrangement of chorismate. 
For AS* to remain zero, however, a corresponding 
number of H-bonds must be broken elsewhere in the 
rearrangement transition structure. Alternatively, some 
H-bonding to 07 already present in the EcCM 
enzyme-substrate complex may become more pro- 
nounced as the rearrangement proceeds, with a com- 
pensatory weakening in H-bonding elsewhere in the 
transition state, most likely in the Cl 1-carboxyl group as 
the enol pyruvate side chain migrates to Cl. 
In the case of BsCM, 07 may likewise form two hydro- 
gen bonds with ArgW to promote the pericyclic 
rearrangement, while maintaining ASS - 0 by forfeiting 
hydrogen bonds elsewhere in the active site. In antibody 
1 F7, however, there are no residues proximal to 07 that 
are capable of forming even one H-bond to the vinyl 
ether moiety (Fig. 1). 
Thus we propose that (i) adjacent, protonated, active site 
residues exert conformational control in the chorismate 
mutase enzyme-substrate complex, and (ii) hydrogen 
bonding between active site residues and 07 of bound 
chorismate catalyzes the rearrangement step. Both mech- 
anistic hypotheses are consistent with all available experi- 
mental data on the chorismate mutase reaction, and are 
amenable to experimental tests on several fronts. These 
hypotheses also suggest what to look for in the modest 
sequence similarities found to date in known mutases. 
One may further expect that antibody 1 lFl-2Ell 
(which enhances rearrangement by 104) will display one 
or more of the key elements that are found in the 
enzyme structures when the solid-state structure of this 
protein is elucidated. 
Future possibilities 
Striking differences between the shallow, exposed active 
site of BsCM and the enclosed, but more spacious, active 
site of EcCM suggest the possibility of designing species- 
specific mutase inhibitors. More interestingly, these find- 
ings suggest that with proper placement of charged 
groups in the substrate, new enzymes may be engineered 
to promote a wide range of pericyclic rearrangements 
based on similar catalytic motifs. 
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It is also possible that understanding how chorismate 
mutase catalyzes its rearrangement may allow the develop- 
ment of rational approaches to the next generation of 
mutase inhibitors. Such inhibitors could be important 
leads for new antibiotics and herbicides. The shikimate 
pathway is the effective site of action of such successful 
drugs as trimethoprim (an inhibitor of dihydrofolate 
reductase) and the sulfa antibiotics (p-aminobenzoate 
mimics which disrupt folate biosynthesis). Chorismate 
mutase inhibitors could join the ranks of these therapeutic 
agents, either as stand-alone drugs or as part of a dual- 
blockade strategy for antibiotic chemotherapy. In either 
case, mutase inhibitors represent a form of treatment 
against which no resistance mechanisms have yet emerged. 
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